Receptors of the seven transmembrane domain family are coupled to heterotrimeric G proteins [1] . Binding of ligand to these receptors induces dissociation of the heterotrimeric complex into free GTP-Gα α and Gβ βγ γ subunits, which then interact with their respective effector molecules to stimulate specific cellular responses. In some cases, these cellular responses involve mitogenic signalling [2] . The mitogen-activated protein (MAP) kinase cascade is initiated by the protein kinase cRaf1 and links growth factor receptor signalling to cell growth and differentiation [3]. The main activator of cRaf1 is the small GTP-binding protein Ras [4] , and the binding of cRaf1 to GTP-Ras translocates cRaf1 to the plasma membrane, where it is activated [5] . It has been reported that cRaf1 associates directly with the β β subunit of heterotrimeric G proteins in vitro, and with the β βγ γ subunit complex in vivo [6], but the role of this association is not yet understood. Here, we show that cRaf1 associates with Gβ β1γ γ2, and that this association in mammalian cells is significantly enhanced when active p21 Ras is present or when cRaf1 is otherwise targeted to the membrane. Association with Gβ β1γ γ2 has no effect on the kinase activity of cRaf1, but cRaf1 can affect Gβ βγ γ-mediated signalling events. Thus, membranelocalised cRaf1 inhibits G-protein-coupled receptor (GPCR)-stimulated activation of phospholipase Cβ β (PLCβ β) ) by sequestration of Gβ βγ γ subunits, an effect also observed with endogenous levels of cRaf1. Our data suggest that cRaf1 may be an important regulator of signalling by Gβ βγ γ, particularly in those GPCR systems that stimulate the MAP kinase cascade through the activation of p21 Ras . 
Results and discussion cRaf1 associates with Gβ β1γ γ2
We found that cRaf1 and Gβγ reciprocally co-immunoprecipitated when they were co-expressed in Sf9 insect cells (data not shown), confirming previously published data [6] . Similar results were observed when cRaf1 and Gβ1γ2 were cotransfected into HEK293 mammalian cells; the degree of this association was significantly enhanced, however, by the presence of an activated mutant of Ha-Ras, HaRas(G12V) with amino acids in the single-letter code ( Figure 1a ). The kinase activity of cRaf1 was not important for its association with Gβγ, because a kinase-dead mutant of cRaf1, cRaf1(K375W), also associated with Gβ1γ2 in the presence of Ha-Ras(G12V). In contrast, a non-Ras binding mutant, cRaf1(R89L), did not associate with Gβ1γ2, either in the presence or the absence of Ha-Ras(G12V). Because the latter mutant of cRaf1 does not associate with the plasma membrane under the conditions used [7] , our data suggest that either Ras binding or membrane translocation is necessary for cRaf1-Gβ1γ2 complex formation.
We next found that plasma-membrane-targeted cRaf1 (cRaf1-CX) associated with Gβγ ( Figure 1b ). This association was independent of Ras or of cRaf1 kinase activity because a non-Ras-binding, kinase-dead mutant cRaf1, cRaf1-CX(R89L,K375W), also coprecipitated Gβ1γ2. Thus, membrane translocation is necessary for the formation of the cRaf1-Gβγ complex. This observation is supported by the fact that the cRaf1-Gβγ complex was isolated mainly from the membrane (P100) fraction of the transfected cells (data not shown). Plasma-membrane-targeted cRaf1 binds lipids [8] and is postulated to change structurally when activated [3, 7] . Moreover, in vitro binding data show a high dissociation constant (K d = 163 ± 36 nM) for the complex [6] , suggesting that membrane targeting of cRaf1 leads to a localised increase in concentration of the components, resulting in the formation of the complex. Whether or not cRaf1 was at the membrane, association with Gβ1γ2 neither enhanced nor inhibited kinase activity (see Supplementary material, and data not shown), indicating that Gβγ is not an activator of cRaf1.
cRaf1 inhibits Gβ βγ γ-induced activation of PLCβ β
These results suggest that binding of cRaf1 may have consequences for Gβγ-mediated signalling. PLCβ2 is activated by Gβγ to hydrolyse phosphatidyl inositol bisphosphate to inositol trisphosphate and diacylglycerol [9] . Co-expression of cRaf1 and Ha-Ras(G12V) reduced Gβ1γ2-mediated PLCβ2 activation by approximately 50%, whereas expression of either of these components alone or co-expression of cRaf1(R89L) and HaRas(G12V) had no effect (Figure 2a) . A similar reduction in Gβ1γ2-mediated activation of PLCβ2 was also induced by expression of cRaf1-CX, and this was independent of the kinase activity of cRaf1 (Figure 2b ). Similar data were also obtained with COS-1 cells (data not shown).
The B2 receptor for the hormone bradykinin activates the MAP kinase cascade in a Ras-dependent manner [10] . Figure 3a shows that bradykinin-induced PLCβ activation in cells transfected with the B2 receptor was inhibited by the co-expression of cRaf1 (25-30% in COS-1 and 30-40% in HEK293 cells) or cRaf1-CX, but not cRaf1(R89L). In the same type of experiment, bradykinin stimulated kinase activity of the wild-type but not the R89L form of cRaf1 (Figure 3b) , confirming that the B2 receptor mediates Ras-induced activation of cRaf1. The B2 receptor is coupled mainly to the Gαq and Gαi proteins [11] and, in our system, pertussis toxin treatment of cells (which inhibits G proteins) inhibited bradykinininduced inositol phosphate production by 25-30% (data not shown). Moreover, PLCs of the β isozyme subfamily can be activated by both Gαq and Gβγ [12] , but cRaf1-CX(R89L,K375W) did not affect PLCβ1 activation by Gαq or Gα11 (Figure 2c ). Thus, our data suggest that Association of cRaf1 with Gβ1γ2 in HEK293 cells. HEK293 cells were transfected with plasmids expressing haemagglutinin (HA)-tagged wild-type (wt) and mutant cRaf1, no protein (pcDNA), Gβ1γ2 and/or Ras(G12V) as indicated, using calcium phosphate precipitation. The transfected cells were lysed with NP40 lysis buffer (150 mM NaCl, 25 mM Na 4 P 2 O 7 , 50 mM Na-glycerophosphate, 2 mM EDTA, 2 mM EGTA, 25 mM Tris pH 8.0, 10% glycerol, 0.5% NP40) containing 10 µg/ml leupeptin, 10 µg/ml aprotinin and 1 mM PMSF as described [20] . The prepared lysates were then immunoprecipitated (2 h, 4°C) with the specific antibodies indicated, which had been pre-adsorbed to protein-A-Sepharose. The immunoprecipitating proteins (IP) were then separated by SDS-PAGE and analysed by western blotting for co-immunoprecipitating proteins. Effect of membrane targeting of cRaf1 on Gβ1γ2-mediated stimulation of PLCβ2. HEK293 cells were cotransfected with the indicated cDNAs as in Figure 1 together with cDNA for PLCβ2 and the levels of basal inositol phosphates compared to mocktransfected control cells (0%) and Gβ1γ2-transfected cells (100%) was determined [21] . The effect of cRaf1 on Gβ1γ2-stimulated PLCβ2 activity (100%) was determined on cells cotransfected with cDNAs encoding (a) cRaf1 or (b) membrane-targeted cRaf1, cRaf1-CX. Similar data were obtained using COS-1 cells (data not shown). The increases in basal inositol phosphates of HEK293 cells were 140 ± 15 cpm per well for transfected Gβ1γ2, 95 ± 10 cpm per well for transfected PLCβ2, and 1860 ± 350 cpm per well for transfected PLCβ2 + Gβ1γ2. (c) The specificity of the cRaf1 inhibition of Gβγ-mediated PLCβ2 stimulation is shown by the inability of cRaf1-CX(R89L,K375W) to inhibit activation of PLCβ1 by Gαq or Gα11. The increases in basal inositol phosphates were 3490 ± 320 cpm per well for transfected PLCβ + Gαq and 6080 ± 720 cpm per well for transfected PLCβ1 + Gα11. Basal inositol phosphate levels of mock-transfected control cells were 320 ± 40 cpm per well. Expression of Gαq, Gα11, or PLCβ1 alone did not significantly increase basal inositol phosphate levels. Data are the means (± SEM) of three or four different experiments. only the Gβγ-mediated component of the bradykinin signal was blocked by activated cRaf1.
In contrast to the B2 receptor, PLCβ activation induced by stimulation of the α 2C adrenergic receptor with the hormone medetomidine is inhibited only by cRaf1-CX (see Supplementary material). The inhibition of the α 2C adrenergic receptor by cRaf1-CX is apparently more complete than inhibition of the B2 receptor, probably because the α 2C adrenergic receptor is coupled to Gαi and stimulation of PLC activity by the α 2C receptor is an effect mediated almost purely by the Gβγ-PLCβ2 interaction. Although the α 2C adrenergic receptor is reported to stimulate the MAP kinase pathway independently of activation of Ras or Raf [13] , in our hands, medetomidine stimulation of transfected cells had no effect on cRaf1 kinase activity (see Supplementary material).
These results suggest that endogenous levels of cRaf1 affect the Gβγ component of bradykinin signalling. Figure 4 shows that co-expression of dominant-negative Ras, Ha-Ras(S17N), in B2-receptor-expressing cells responding to bradykinin stimulation led to enhancement of both inositol phosphate production and fluxes in intracellular calcium. As Ha-Ras(S17N) inhibited the ability of bradykinin to induce association of cRaf1 with the plasma membrane of these cells (Figure 4d) , the increased responses that we observed indicate that endogenous cRaf1 indeed limits the Gβγ component of bradykinininduced PLCβ activation.
Taken together, our data suggest an antagonistic regulation of GPCRs by the MAP kinase cascade through interaction of cRaf1 with free Gβγ. Although this crosstalk is independent of the catalytic activity of cRaf1, membrane recruitment of the kinase seems essential. This phenomenon is of particular interest in GPCR systems that activate the MAP kinase cascade through the generation of GTPloaded Ras [14] . Our data reveal a feedback mechanism in which the Gβγ signalling component of GPCRs is limited by the membrane recruitment of cRaf1. As the binding affinities of the Gβγ-cRaf1 and Gβγ-PLCβ2 complexes are in the same range [6, 15, 16] , it is possible that PLCβ2 and Ras-bound cRaf1 can compete for free Gβγ in the membrane. Our data suggest that cRaf1, in addition to its function in the MAP kinase cascade, has a role resembling that of the protein phosducin, which, similar to cRaf1, is expressed ubiquitously [17] , inhibits Gβγ-mediated signalling pathways [18] , and can be regulated [19] . In our model, we propose downregulation of GPCR signals as a consequence of the tightly controlled membrane recruitment of Raf. This novel function of cRaf1 underlines the notion that this kinase is an integral component of multiple cellular pathways.
Supplementary material
Supplementary material including two supplementary figures and additional methodological details is available at http://currentbiology.com/supmat/supmatin.htm.
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Figure 3
Effect of cRaf1 on GPCR-stimulated increase of inositol phosphate levels in bradykinin B2-receptor-transfected cells. The rise in intracellular Ca 2+ was then determined as described using cells (1 × 10 6 ) that had incorporated Fura2 into their cytosols [22] . Data are representative of three or four different experiments. (d) Western blot analysis showing that Ha-Ras(S17N) inhibits bradykinin-induced association of endogenous cRaf1 with the plasma membrane of B2-receptortransfected HEK293 cells. Cells transfected with B2 receptor with or without Ha-Ras(S17N) were stimulated with 1 µM bradykinin for the indicated times and the membrane fraction (P100) was isolated. Protein concentration was equalised between the various samples prior to separation by SDS-PAGE and western blotting with anticRaf1 antibodies. 
Binding of Gβ
Supplementary materials and methods
Materials
All HA-tagged cRaf1 proteins, including wild-type, R89L and K375W mutants, a HA-cRaf1 modified at the carboxy terminus with the last 17 amino acids from Ki-Ras, including the CAAX sequence (HA-cRaf1-CX), and Ha-Ras(G12V), Gβ1, Gγ2, α 2C adrenergic receptor, bradykinin B2 receptor and phospholipase Cβ2 were expressed from pcDNA3 (Invitrogen) vector constructs. The anti-HA monoclonal antibody was purified from hybridoma (12CA5) cell lines (American Type Culture Collection). Anti-cRaf1 rabbit polyclonal antibodies were generated and characterised as described [S1]. Anti-Gβ antibodies were purchased from Santa Cruz biotechnology. Protein-A-Sepharose was purchased from Boehringer Mannheim. Enhanced chemoluminescence reagents, film and [γ 32 P]ATP were purchased from Amersham Pharmacia.
Expression of proteins in insect (Spodoptera frugiderda) SF9 cells
The cRaf1, lck, Ras(G12V), and Gβ1γ2 protein viral expression constructs were prepared as described [S2,S3] . Infection and harvest of cells were performed using an established protocol [S4] . 
Mammalian cell transfections
Supplementary material
Figure S1
Association of cRaf1 with Gβ1γ2 in HEK293 cells does not influence cRaf1 protein kinase activity. HEK293 cells were transfected with the indicated protein expression constructs (as in Figure 1 ) and lysed with NP40 lysis buffer. The experiment shown is an immune-complex kinase assay using the immunoprecipitated material (IP) 4 3-incorporation into MEK(K97M) did not reveal any significant increase in cRaf1 activity when cRaf1 or cRaf1-CX were co-expressed with Gβ1γ2 (data not shown). 
Figure S2
Effect of cRaf1 on GPCR-stimulated increase of inositol phosphate levels in α 2C -adrenergic-receptor-transfected cells. (a) HEK293 cells were transfected with a cDNA encoding the mouse α 2C adrenergic receptor and the levels of inositol phosphates compared with cells stimulated with 1 × 10 -6 M medetomidine was determined. The effect of cRaf1 expression on the signal induced by medetomidine (100%) was determined on cells cotransfected with cDNAs encoding the same constructs of cRaf1 that were used with the B2 receptor ( Figure 3 
